Abstract
Purpose: To explore the effectiveness of flexible bronchoscopy in pediatric Mycoplasma pneumoniae pneumonia (MPP).
Methods: This retrospective cohort study included children with MPP admitted between 2016 and 2019 in Shanghai. Tracheobronchial manifestations, etiologic findings, therapeutic effect, and health-economic indicators were assessed in bronchoscopy (plus bronchoalveolar lavage (BAL)) and non-bronchoscopy group. We used propensity-score matching and multivariable logistic regression to investigate the effect of bronchoscopy and BAL on disease recovery.
Results: In 900 children with MPP, 24/278 (8.6%) of those who underwent bronchoscopy had sputum plugs. Coinfection rate was four-fold enhanced by BAL (19.6% vs. 4.5%, p < 0.01) in patients with severe MPP (SMPP) and nearly doubled (10.8% vs. 5.9%, p = 0.03) in those without SMPP, compared with no BAL. Total of 224 (24.9%) patients had multilobar consolidation; after BAL, a significantly shorter lesion-resolution duration was observed on imaging (OR: 0.2, 95% CI: 0.0-0.7). However, longer fever duration (OR: 2.8, 95% CI: 1.7-4.8), hospital stay (OR: 3.1, 95% CI: 1.9-5.1), and higher costs were found in the bronchoscopy group than in the non-bronchoscopy group.
Conclusions: Through BAL, coinfection may explain one-fifth of causes for SMPP. Bronchoscopy with BAL may increase the detection rate of pathogen and resolve pulmonary lesions in patients with multilobar consolidation.
Impact: Flexible bronchoscopy with bronchoalveolar lavage is of great assistance in the timely detection of coinfection, sputum plug and inflammatory polyps in children with Mycoplasma pneumoniae pneumonia (MPP), and improves the recovery of lung damage in MPP patients with multilobar consolidation. This study provides new insights into the indications of flexible bronchoscopy for the diagnosis and treatment of pediatric patients with MPP.
Β© 2022. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.
References
-
- Jain, S. et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N. Engl. J. Med. 372, 835β845 (2015). - DOI
-
- Morozumi, M., Takahashi, T. & Ubukata, K. Macrolide-resistant mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J. Infect. Chemother. 16, 78β86 (2010). - DOI
-
- Tamura, A. et al. Methylprednisolone pulse therapy for refractory mycoplasma pneumoniae pneumonia in children. J. Infect. 57, 223β228 (2008). - DOI
-
- Zhang, Y. et al. The clinical characteristics and predictors of refractory Mycoplasma Pneumoniae pneumonia in children. PLoS ONE 11, e0156465 (2016). - DOI
-
- Kutty, P. K. et al. Mycoplasma Pneumoniae among children hospitalized with community-acquired pneumonia. Clin. Infect. Dis. 68, 5β12 (2019).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
